See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.44▲ 3.99%
← 0OA9 page
XStocksXray
Market X-Ray report · 23 October 2026

Nolato AB ser. B (0OA9)

London Exchange · UK · prices in SEK · close of 23 Oct 2026

Key indicators

Last closeSEK 54.90
52-week range45.82 – 64.65
Return, 1 month / 3 months+0.7% / +14.6%
Return, 1 year / 3 years−4.6% / +20.4%
TrendUptrend
RSI (14)46
Volatility (1 year)25.1%
Worst drawdown (1 year)-26.0%
Average daily value traded0.96M SEK
Dividend yield3.1%

Market X-Ray price-based

62/ 100 · High confidence · ahead of 69% of stocks on this exchange
Trend67
Momentum64
Stability (higher is calmer)66
Liquidity52
Income47

Five-year price chart navy: price · brown: 200-day average

33.2551.8670.4789.081082021-102023-012024-042025-072026-10

About the company

Nolato AB is a Swedish industrial group that develops and manufactures polymer components and systems. It makes plastic and silicone parts, medical device components, packaging and precision products for customers in the medical technology, automotive, electronics and consumer goods industries. The company works closely with industrial customers that need customised components and integrated manufacturing services, and it is based in Sweden.

On this site Nolato AB ser. B appears as a stock on the London Exchange (UK), code 0OA9, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Nolato AB ser. B (0OA9) trades on the London Exchange in UK. It last closed at SEK 54.90 on 23 October 2026.

Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 1,182 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 4.6% and over the last three months it rose 14.6%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Nolato AB ser. B (0OA9)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend67 · FairMixed trend against its averages.
Above 200-day average7.5%
From 52-week high-13.7%
Momentum64 · FairTypical recent returns for this exchange.
3-month return14.6%
6-month return10.5%
12-month return, skipping the last month-5.3%
Stability (higher is calmer)66 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)25.1%
Worst drawdown, 1 year (smaller is calmer)-26.0%
Liquidity52 · FairModerate trading activity.
Average daily value traded0.96M SEK
Zero-volume days0.0%
Income47 · WeakDividend is small or irregular.
Dividend yield3.1%
Years with dividends5

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Income: Dividend is small or irregular.

Returns

1 week−4.0%
1 month+0.7%
3 months+14.6%
6 months+10.5%
1 year−4.6%
3 years+20.4%
5 years−43.9%

Signals

50-day / 200-day average54.03 / 51.05
Golden / death cross (60 days)Golden, 18 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.82

Technical summary

DailyBullish9 bullish · 2 neutral · 5 bearish
WeeklyStrongly bullish11 bullish · 1 neutral · 0 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish

Recent dividends

Ex-dividend dateAmount per share
7 May 2026SEK 1.7000
7 May 2025SEK 1.5000
7 May 2024SEK 1.5000
4 May 2023SEK 1.9000
4 May 2022SEK 1.9000
5 May 2021SEK 16.0000

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026